| Mutant p53 disrupts mammary tissue architecture via the mevalonate pathway WA Freed-Pastor, H Mizuno, X Zhao, A Langerød, SH Moon, ... Cell 148 (1), 244-258, 2012 | 888 | 2012 |
| PrognoScan: a new database for meta-analysis of the prognostic value of genes H Mizuno, K Kitada, K Nakai, A Sarai BMC medical genomics 2, 1-11, 2009 | 881 | 2009 |
| Identification of Genes Upregulated in ALK-Positive and EGFR/KRAS/ALK-Negative Lung Adenocarcinomas H Okayama, T Kohno, Y Ishii, Y Shimada, K Shiraishi, R Iwakawa, ... Cancer research 72 (1), 100-111, 2012 | 777 | 2012 |
| Molecular classification of prostate cancer using curated expression signatures EK Markert, H Mizuno, A Vazquez, AJ Levine Proceedings of the National Academy of Sciences 108 (52), 21276-21281, 2011 | 217 | 2011 |
| The Dictyostelium Developmental cDNA Project: Generation and Analysis of Expressed Sequence Tags from the First-Finger Stage of Development T Morio, H Urushihara, T Saito, Y Ugawa, H MiZUNO, M Yoshida, ... DNA research 5 (6), 335-340, 1998 | 192 | 1998 |
| Inactivation of p53 in breast cancers correlates with stem cell transcriptional signatures H Mizuno, BT Spike, GM Wahl, AJ Levine Proceedings of the National Academy of Sciences 107 (52), 22745-22750, 2010 | 190 | 2010 |
| The AURKA/TPX2 axis drives colon tumorigenesis cooperatively with MYC Y Takahashi, P Sheridan, A Niida, G Sawada, R Uchi, H Mizuno, ... Annals of oncology 26 (5), 935-942, 2015 | 104 | 2015 |
| Anti-GPRC5D/CD3 bispecific T-cell–redirecting antibody for the treatment of multiple myeloma T Kodama, Y Kochi, W Nakai, H Mizuno, T Baba, K Habu, N Sawada, ... Molecular cancer therapeutics 18 (9), 1555-1564, 2019 | 60 | 2019 |
| A signature-based method for indexing cell cycle phase distribution from microarray profiles H Mizuno, Y Nakanishi, N Ishii, A Sarai, K Kitada BMC genomics 10, 1-10, 2009 | 39 | 2009 |
| ERK signal suppression and sensitivity to CH5183284/Debio 1347, a selective FGFR inhibitor Y Nakanishi, H Mizuno, H Sase, T Fujii, K Sakata, N Akiyama, Y Aoki, ... Molecular cancer therapeutics 14 (12), 2831-2839, 2015 | 30 | 2015 |
| Topological analysis of gene expression arrays identifies high risk molecular subtypes in breast cancer J Arsuaga, NA Baas, D DeWoskin, H Mizuno, A Pankov, C Park Applicable Algebra in Engineering, Communication and Computing 23, 3-15, 2012 | 18 | 2012 |
| ORI-GENE: gene classification based on the evolutionary tree H Mizuno, Y Tanaka, K Nakai, A Sarai Bioinformatics 17 (2), 167-173, 2001 | 11 | 2001 |
| Geography-dependent horizontal gene transfer from vertebrate predators to their prey C Kambayashi, R Kakehashi, Y Sato, H Mizuno, H Tanabe, ... Molecular Biology and Evolution 39 (4), msac052, 2022 | 10 | 2022 |
| Fine-scale detection of population-specific linkage disequilibrium using haplotype entropy in the human genome H Mizuno, G Atwal, H Wang, AJ Levine, A Vazquez BMC genetics 11, 1-10, 2010 | 8 | 2010 |
| Involvement of cyclooxygenase‐2 in the tumor site‐dependent production of parathyroid hormone‐related protein in colon 26 carcinoma H Saito, Y Inagaki, T Tsunenari, M Ura, H Mizuno, K Fujimoto‐Ouchi, ... Cancer science 98 (10), 1563-1569, 2007 | 7 | 2007 |
| The PFA-AMeX method achieves a good balance between the morphology of tissues and the quality of RNA content in DNA microarray analysis with laser-capture microdissection samples T Watanabe, A Kato, H Terashima, K Matsubara, YJ Chen, K Adachi, ... Journal of toxicologic pathology 28 (1), 43-49, 2015 | 3 | 2015 |
| Neutrophil-to-lymphocyte ratio is a prognostic factor reflecting immune condition of tumor microenvironment in squamous cell lung cancer K Ohashi, Y Nishito, H Fukuda, R Sadahiro, Y Yoshida, S Watanabe, ... Scientific Reports 14 (1), 429, 2024 | 1 | 2024 |
| Tumor-infiltrating leukocyte profiling defines three immune subtypes of NSCLC with distinct signaling pathways and genetic alterations K Aoki, Y Nishito, N Motoi, Y Arai, N Hiraoka, T Shibata, Y Sonobe, ... Cancer Research Communications 3 (6), 1026-1040, 2023 | 1 | 2023 |
| Molecular subtypes of lung adenocarcinoma present distinct immune tumor microenvironments H Fukuda, K Arai, H Mizuno, Y Nishito, N Motoi, Y Arai, N Hiraoka, ... Cancer Science, 2024 | | 2024 |
| Rapid in vitro assessment of the immunogenicity potential of engineered antibody therapeutics through detection of CD4+ T cell interleukin-2 secretion Y Arata, S Motoyama, M Yano, T Ikuno, S Ito, T Matsushita, A Takeiri, ... Mabs 15 (1), 2253570, 2023 | | 2023 |
Akinori SaraiProfessor, Kyushu Institute of TechnologyVerified email at sanzo.org
